Clinical Trial Update: Combination of Ertugliflozin And Sitagliptin Efficacy, Safety & Tolerability (CEASE Diabetes) Study

View source ↗

Summary

The CEASE Diabetes trial evaluated the efficacy, safety, and tolerability of combining ertugliflozin with sitagliptin for Type 2 diabetes and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Januvia (sitagliptin)
• STEGLATRO (ertugliflozin)

Snippet

Sponsor: Getz Pharma | Conditions: Efficacy, Safety | Status: COMPLETED